Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Lasers in Surgery and Medicine|November 8, 2011
Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapyShouyan Wang, Wenzhe Fan, Gwangseong Kim, et al.JAMA Oncology|June 20, 2024
Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma: Sorafenib Plus TACE vs TACE Alone Randomized Clinical TrialWenzhe Fan, Bowen Zhu, Shuling Chen, et al.Journal of Hepatocellular Carcinoma|March 25, 2025
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP ScoreWenzhe Fan, Xinlin Zheng, Weihong Zhang, et al.Radiology|May 6, 2025
Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV TrialHaikuan Liu, Wenzhe Fan, Haiqing Li, et al.JAMA Surgery|April 3, 2024
Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus: A Randomized Clinical TrialZhenwei Peng, Wenzhe Fan, Zelong Liu, et al.Journal of Hepatology|March 8, 2023
TREM2<sup>+</sup> macrophages suppress CD8<sup>+</sup> T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinomaJizhou Tan, Wenzhe Fan, Ting Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2022
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)Zhenwei Peng, Wenzhe Fan, Bowen Zhu, et al.European Radiology|December 23, 2022
Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational studyWenzhe Fan, Bowen Zhu, Shufan Yue, et al.Liver Cancer|August 18, 2022
Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective StudyDongdong Xia, Wei Bai, Enxin Wang, et al.European Radiology|April 6, 2022
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolizationDongdong Xia, Qiuhe Wang, Wei Bai, et al.Pageof 10